Bringing the fundamentals into focus…
Back to Amneal Pharmaceuticals, Inc.
How Amneal Pharmaceuticals, Inc. stacks up
AMRX · against 187 other Healthcare companies of similar size
Growth
89/ 100
Near the top of its peers.
Ranked #26 of 188 · scores higher than 86% of peers
Bars: peers in each 10-point band of the growth score27 peers with a growth score of 80–89, including AMRX · Click a bar to see the companies
Why growth scores 89?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- Revenue growth is close to the peer norm. Revenue growth: 9.3% vs peer median 6.1%
- faster revenue growth over three years: stronger than 63% of peers. 3-year revenue growth: 10.5% vs peer median 5.8%
- faster growth in earnings per share: stronger than 100% of peers. Earnings per share growth: 4485.6% vs peer median 9.8%
Metric by metric
Position: dot = AMRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AMRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 188 reported | 9.3% | 9.3% | 50% | 33% | |
| Earnings per share growthHigher is better · 130 reported | 4485.6% | 10.8% | 100% | 33% | |
| 3-year revenue growthHigher is better · 182 reported | 10.5% | 9.6% | 51% | 33% |
Ranking by growth score
Top 5 and the companies ranked around AMRX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 2 | 3.8B USD | 98 | 71 | |
| 2 | 9.3B USD | 98 | 64 | |
| 5 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 22 | 5.7B USD | 90 | 30 | |
| 22 | 7.4B USD | 90 | 67 | |
| 22 | 3.8B USD | 90 | 48 | |
| 26 | 68.9B HKD (≈$8.8B) | 89 | 67 | |
| 26 | 7.0B USD | 89 | 57 | |
| 26 | 13.8B USD | 89 | 54 | |
| 29 | 4.3B USD | 88 | 69 | |
| 29 | 4.6B USD | 88 | 61 | |
| 29 | 14.0B USD | 88 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score